Brief: Geneuro publishes data supporting role of retroviral pathogenic envelope protein in type 1 diabetes

Geneuro SA

11/09/2017 06:31

Sept 11 (Reuters) - GENEURO SA  GNRO.PA : 
    * GENEURO AND COLLABORATORS PUBLISH DATA SUPPORTING ROLE OF 
RETROVIRAL PATHOGENIC ENVELOPE PROTEIN IN TYPE 1 DIABETES (T1D) 
    * GENEURO HAS INITIATED A RANDOMIZED, PLACEBO-CONTROLLED 
PHASE 2A STUDY TO EVALUATE GNBAC1 IN 60 RECENTLY DIAGNOSED ADULT 
PATIENTS 
    * PRIMARY ENDPOINT OF STUDY IS SAFETY OF GNBAC1 IN THIS NEW 
POPULATION OF PATIENTS 
    * SECONDARY ENDPOINTS WILL MEASURE LINK BETWEEN TREATMENT 
RESPONSE AND PHERV-W ENV BIOMARKERS OF PANCREATIC FUNCTION, 
INSULIN PRODUCTION 
    * PRELIMINARY RESULTS ARE EXPECTED DURING Q3 2018. 
 
Source text for Eikon:  ID:nBw9jbD22a  
Further company coverage:  GNRO.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))